Ideas and analysis shaping decisions across the industry

HCP+PATIENT INSIGHTS

Physicians Are People First. Prescribers Second.

Pharma knows more about what physicians prescribe than almost any industry knows about its audience - but far less about why. A look at how understanding the beliefs, identity, and cognitive patterns behind HCP decision-making unlocks better strategy than behavioral data alone ever can.

Apr 28, 2026

S+R NEWS

Shapiro+Raj Launches an AI Agent Built Specifically for the Life Sciences Industry

Shapiro+Raj announces the expansion of Stella.ai as a direct offering for life sciences teams, with new leadership appointments to scale the platform's growth in pharma and biotech insights.

Apr 22, 2026

PHARMA BRANDING

Clinical Science Built Pharma. A Brand Will Decide Who Survives.

Clinical differentiation alone no longer guarantees market leadership. A look at why pharma is at the same brand-defining inflection point that reshuffled consumer packaged goods decades ago - and what companies must do now to build the trust, memory, and meaning that turns a strong molecule into a durable brand.

Feb 24, 2026

AI+TECHNOLOGY

5 Causes of Hallucination in Insights AI

A breakdown of the five critical reasons insights AI hallucinates — from misinterpreting complex visuals to blending contradictory sources — and what it takes to build an AI that market research teams can actually trust.

Jul 23, 2025

PHARMA BRANDING

From Molecule to Movement. Rethinking Pharma Branding in the Age of GLP-1s.

GLP-1s haven't just reshaped treatment — they've rewritten the rules of pharma branding. An examination of how the rise of consumer-driven healthcare is forcing brands to compete on identity, trust, and cultural relevance, not just clinical data.

Jul 20, 2025

PHARMA BRANDING

The Power of Perspectives. The Most Strategic Imperative in Today’s Fragmented World.

In a fragmented world, perspective is the most strategic imperative brands have. A look at why the organizations that invest in understanding diverse viewpoints — from patients to payers to prescribers — build the strongest commercial positions.

Jul 9, 2025